Mosaic ImmunoEngineering, a biotechnology company in Huntington Beach, California, is developing MIE-101, an early-stage cancer treatment derived from Cowpea mosaic virus. The firm aims to enhance immunotherapy through additional product candidates and partnerships.
Sector
💻 Information Technology
IPO
CEO
Employees
Headquarters
California, USA
Recently from Cashu
No Cashu articles
Mosaic ImmunoEngineering currently has no Cashu-related articles
